Vivek Ramaswamy Parents: Meet V.G. Ramaswamy and Geetha
Vivek Ramaswamy Parents: Meet V.G. Ramaswamy and Geetha – Vivek Ramaswamy is an American entrepreneur and biotech investor. He was born on August 9, 1985, in Cincinnati, Ohio, to Indian immigrant parents.
Ramaswamy attended Harvard University, where he received a bachelor’s degree in molecular and cellular biology in 2007. He went on to study law at Yale Law School, where he received his JD in 2013.
Ram aswamy began his career in biotech investment banking at Qatalyst Partners, a boutique investment bank, where he worked on mergers and acquisitions in the pharmaceutical industry. In 2013, he left Qatalyst to become a partner at MPM Capital, a healthcare-focused venture capital firm. At MPM, Ramaswamy led investments in biotech companies such as Arvinas, Kymera Therapeutics, and TCR2 Therapeutics.
In 2014, Ramaswamy founded Roivant Sciences, a biopharmaceutical company that aims to develop and commercialize innovative therapies for diseases with high unmet medical needs. Roivant is organized as a “v-family” of subsidiary companies, each of which focuses on a specific therapeutic area or technology platform. Ramaswamy’s vision for Roivant was to create a decentralized model for drug development that could accelerate the pace of innovation in the pharmaceutical industry.
Under Ramaswamy’s leadership, Roivant has raised over $3 billion in funding and has launched multiple subsidiaries focused on drug development. Some of Roivant’s notable subsidiaries include:
- Axovant Sciences, which is developing gene therapies for neurological disorders such as Parkinson’s disease and Alzheimer’s disease.
- Myovant Sciences, which is developing therapies for women’s health conditions such as uterine fibroids and endometriosis.
- Dermavant Sciences, which is developing therapies for dermatological conditions such as psoriasis and atopic dermatitis.
Roivant has also launched subsidiary companies focused on drug discovery, drug delivery, and artificial intelligence in drug development. In 2017, Roivant went public through a special purpose acquisition company (SPAC) merger with Axovant Sciences.
In addition to his work at Roivant, Ramaswamy has been active in advocating for changes in the pharmaceutical industry. He has criticized the high cost of drugs and the slow pace of innovation, and has called for greater transparency and accountability in drug pricing. In 2018, Ramaswamy published a book called “Woke, Inc.: Inside Corporate America’s Social Justice Scam,” in which he criticized what he saw as the politicization of corporate America.
Ramaswamy has been recognized for his entrepreneurship and philanthropy. In 2019, he was named to Forbes’ 30 Under 30 list in healthcare.
Vivek Ramaswamy Parents: Meet V.G. Ramaswamy and Geetha
Vivek Ramaswamy’s parents are immigrants from Vadakkencherry, Palakkad, Kerala, India. His father, V.G. Ramaswamy, graduated from a regional engineering college in Kerala before moving to the United States. He later found employment at the General Electric Plant in Evendale, Ohio. On the other hand, Vivek’s mother, Geetha, worked as a geriatric psychiatrist in Cincinnati.
Ramaswamy has expressed that the American economic system provides a solution to the caste system in India. He believes that the capitalist system in the United States offers individuals from lower-caste backgrounds increased economic opportunities that may not be as accessible in India due to its entrenched caste system. Ramaswamy has not gone into detail regarding his personal experiences with the caste system, but he has stated that his parents’ immigrant background has played a significant role in his worldview and experiences.
